70 related articles for article (PubMed ID: 6119712)
1. Initial improvement as predictor of outcome of neuroleptic treatment.
Nedopil N; Rüther E
Pharmacopsychiatria; 1981 Nov; 14(6):205-7. PubMed ID: 6119712
[TBL] [Abstract][Full Text] [Related]
2. The prediction of acute response, remission and general outcome of neuroleptic treatment in acute schizophrenic patients.
Nedopil N; Pflieger R; Rüther E
Pharmacopsychiatria; 1983 Nov; 16(6):201-5. PubMed ID: 6141576
[TBL] [Abstract][Full Text] [Related]
3. [Prediction of therapeutic success in acute neuroleptic treatment: results of an empirical study of 243 inpatient-treated schizophrenic patients].
Möller HJ; Scharl W; von Zerssen D
Fortschr Neurol Psychiatr; 1985 Oct; 53(10):370-83. PubMed ID: 2866152
[TBL] [Abstract][Full Text] [Related]
4. [Modification of long-term schizophrenia by somato-therapeutic measures].
Gross G; Huber G; Schüttler R
Psychiatr Clin (Basel); 1980; 13(3-4):179-92. PubMed ID: 6113621
[TBL] [Abstract][Full Text] [Related]
5. [Erythrocyte ketone reductase activity, total plasma haloperidol and acute psychoses].
Dutoit D; Thomas P; Leroux JM; Vaiga G; Pommery J; Cottencin O; Erb F; Goudemand M
Encephale; 1995; 21(6):417-24. PubMed ID: 8674466
[TBL] [Abstract][Full Text] [Related]
6. [Changes in the health state of schizophrenic patients in neuroleptic therapy].
Heim M
Psychiatr Neurol Med Psychol (Leipz); 1986 Aug; 38(8):483-7. PubMed ID: 2878452
[TBL] [Abstract][Full Text] [Related]
7. [Neuroleptic treatment and neurological soft signs in schizophrenic patients].
Mechri A; Slama H; Chebel S; Mandhouj O; Gaha L
Therapie; 2007; 62(5):449-53. PubMed ID: 18206107
[TBL] [Abstract][Full Text] [Related]
8. [A differential effect profile of neuroleptic therapy of acute schizophrenic patients? Results of a clinico-naturalistic study].
Schmidt LG; Siemetzki H
Nervenarzt; 1988 Dec; 59(12):721-6. PubMed ID: 2905770
[No Abstract] [Full Text] [Related]
9. [Neuroleptic large dose therapy of schizophrenias].
Ungvári G; Pethö B
Psychiatr Neurol Med Psychol (Leipz); 1981 Apr; 33(4):230-6. PubMed ID: 6114506
[TBL] [Abstract][Full Text] [Related]
10. [Antidepressive effect of pyridoxine (vitamin B6) in neuroleptic-treated schizophrenic patients with co-morbid minor depression--preliminary open-label trial].
Shiloh R; Weizman A; Weizer N; Dorfman-Etrog P; Munitz H
Harefuah; 2001 May; 140(5):369-73, 456. PubMed ID: 11419053
[TBL] [Abstract][Full Text] [Related]
11. Can changes in eye-contacts predict therapeutic outcome in schizophrenic patients undergoing neuroleptic treatment? Results of a preliminary study.
Meya U; Renfordt E
Pharmacopsychiatry; 1986 Nov; 19(6):429-33. PubMed ID: 2879296
[TBL] [Abstract][Full Text] [Related]
12. Plasma homovanillic acid levels and therapeutic outcome in schizophrenics: comparisons of neuroleptic-naive first-episode patients and patients with disease exacerbation due to neuroleptic discontinuance.
Akiyama K; Tsuchida K; Kanzaki A; Ujike H; Hamamura T; Kondo K; Mutoh S; Miyanagi K; Kuroda S; Otsuki S
Biol Psychiatry; 1995 Nov; 38(10):639-48. PubMed ID: 8555375
[TBL] [Abstract][Full Text] [Related]
13. Suspension of neuroleptic therapy in acute schizophrenia.
Kuhs H; Eikelmann B
Pharmacopsychiatry; 1988 Jul; 21(4):197-202. PubMed ID: 2905064
[TBL] [Abstract][Full Text] [Related]
14. Predicting outcome of neuroleptic treatment on the basis of subjective response and early clinical improvement.
Bartkó G; Herczeg I; Békésy M
J Clin Psychiatry; 1987 Sep; 48(9):363-5. PubMed ID: 3624207
[TBL] [Abstract][Full Text] [Related]
15. [Psychopathometric study of the prognostic significance of psychopathologic findings and premorbid personality for discharge of neuroleptic treated patients with schizophrenic psychoses].
Möller HJ; von Zerssen D
Nervenarzt; 1985 Sep; 56(9):498-505. PubMed ID: 2867479
[No Abstract] [Full Text] [Related]
16. [Long-term therapy of chronic schizophrenic patients with haloperidol decanoate].
Roncoroni D
Psychiatr Prax; 1984 Mar; 11(2):56-8. PubMed ID: 6144121
[TBL] [Abstract][Full Text] [Related]
17. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
Midha KK; Hubbard JW; Marder SR; Marshall BD; Van Putten T
J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
[TBL] [Abstract][Full Text] [Related]
18. [Zotepine: treatment of schizophrenic patients with predominantly negative symptoms. A double-blind study vs. haloperidol].
Barnas C; Stuppäck CH; Miller C; Haring C; Sperner-Unterweger B; Fleischhacker WW
Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():36-40. PubMed ID: 1683338
[TBL] [Abstract][Full Text] [Related]
19. Duration of neuroleptic treatment and relapse rate: a 5-year follow-up study with haloperidol decanoate.
Youssef HA
Clin Neuropharmacol; 1991; 14 Suppl 2():S16-21; discussion S22-3. PubMed ID: 1684308
[TBL] [Abstract][Full Text] [Related]
20. Neuroleptic levels by radioreceptor assay and clinical response during treatment of acute exacerbation of schizophrenia--some preliminary findings.
Greenberg JS; Brown WA; Laughren TP; Krantz J
Psychopharmacol Bull; 1983; 19(1):74-6. PubMed ID: 6131470
[No Abstract] [Full Text] [Related]
[Next] [New Search]